↓ Skip to main content

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic…

Overview of attention for article published in Systematic Reviews, March 2023
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis
Published in
Systematic Reviews, March 2023
DOI 10.1186/s13643-023-02221-5
Pubmed ID
Authors

Caroline Kamp Jørgensen, Sophie Juul, Faiza Siddiqui, Mark Abie Horowitz, Joanna Moncrieff, Klaus Munkholm, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 20%
Other 1 10%
Student > Doctoral Student 1 10%
Lecturer 1 10%
Researcher 1 10%
Other 1 10%
Unknown 3 30%
Readers by discipline Count As %
Psychology 3 30%
Medicine and Dentistry 2 20%
Neuroscience 1 10%
Engineering 1 10%
Unknown 3 30%